The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
ScienceAlert on MSN
HIV's Cunning Strategy For Hiding in Our Body Finally Revealed
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more? CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...
Morning Overview on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...
Sri Lanka is facing a serious public health crisis, with more than 150,000 individuals engaging in unsafe sexual and ...
The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.
South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...
A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state ...
Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback